Ypsomed AG

Ypsomed is the leading developer and manufacturer of self-injection systems for liquid medications, offering the most comprehensive and innovative platform portfolio for pens, autoinjectors and on-body devices. Backed by a proven track record of over 40 years, Ypsomed's tailored solutions are delivered with best-in-class execution and ready to integrate with digital health services, headquartered in Burgdorf, Switzerland, employing more than 2,000 people worldwide committed to making self-care simpler and easier.